Invention Grant
- Patent Title: TMPRSS6 iRNA compositions and methods of use thereof
-
Application No.: US16191579Application Date: 2018-11-15
-
Publication No.: US10913950B2Publication Date: 2021-02-09
- Inventor: James Butler , Brian Bettencourt , Kallanthottathil G. Rajeev , Martin A. Maier , Klaus Charisse
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Maria Laccotripe Zacharakis; Deborah L. Nagle
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/04 ; C12N15/113 ; C12N9/64
Abstract:
The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the TMPRSS6 gene, and methods of using such RNAi agents to inhibit expression of TMPRSS6 and methods of treating subjects having a TMPRSS6 associated disorder, e.g., an iron overload associated disorder, such as β-thalassemia or hemochromatosis.
Public/Granted literature
- US20190211341A1 TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2019-07-11
Information query
